Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

More robust analysis with new Geneious Biologics release
January 2018
SHARING OPTIONS:

SAN DIEGO—A December announcement from Geneious Biologics shared word of a new release that will significantly improve analysis of large-scale next-generation sequencing datasets, in order to better equip researchers to analyze antibody sequences to speed the identification of antibody candidates. The release was announced at the Antibody Engineering & Therapeutics Conference in San Diego.
 
“Geneious Biologics now has the power to analyze millions of NGS raw antibody sequences in minutes. The software lets users preview, annotate and compare NGS sequences with no manual intervention,” said Jannick Bendtsen, vice president of technology services for Biomatters. “This is a big milestone for Geneious Biologics and a huge step forward on our development roadmap. High-throughput antibody sequencing technologies are revolutionizing the biologic drug discovery industry. However, dealing with huge volumes of associated data remains a challenge. Geneious Biologics now offers a real solution.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.